Clinical Trial Update: Immunogenicity of 9-valent HPV Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the immunogenicity of a 9-valent HPV vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• 9-valent HPV vaccine

Snippet

Sponsor: Talia Sainz Costa | Conditions: Human Papilloma Virus Infection | Phase 4 | Status: UNKNOWN